Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Frontiers in Pharmacology|December 12, 2018
PIN1 in Cell Cycle Control and CancerChi-Wai Cheng, Eric TseFrontiers in Cell and Developmental Biology|February 4, 2020
Targeting PIN1 as a Therapeutic Approach for Hepatocellular CarcinomaChi-Wai Cheng, Eric TseWorld Journal of Gastroenterology|December 27, 2016
Understanding the role of PIN1 in hepatocellular carcinomaChi-Wai Cheng, Ka-Wai Leong, Eric TseThe Journal of Biological Chemistry|November 10, 2017
The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27Chi-Wai Cheng, Ka-Wai Leong, Yiu-Ming Ng, et al.Oncotarget|January 12, 2017
miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expressionKa-Wai Leong, Chi-Wai Cheng, Chun-Ming Wong, et al.The American Journal of Pathology|January 22, 2013
PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivinChi-Wai Cheng, Ariel K M Chow, Roberta Pang, et al.Developmental Cell|August 18, 2012
The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopmentMattia Frontini, Alexander Kukalev, Elisabetta Leo, et al.Public Health Nutrition|November 23, 2022
Trans-fat labelling information on prepackaged foods and beverages sold in Hong Kong in 2019Christopher Chi Wai Cheng, Jason Hy Wu, Jimmy Chun Yu LouieCancers|February 15, 2022
Recent Advances in the Diagnosis and Treatment of Natural Killer Cell MalignanciesEric Tse, Yok-Lam KwongSeminars in Cancer Biology|June 10, 2015
T-cell lymphoma: Microenvironment-related biomarkersEric Tse, Yok-Lam KwongPageof 16